Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Emicerfont is an antagonist of the corticotropin-releasing factor type 1 receptor (IC50: 66 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,970.00 | |
50 mg | 8-10 weeks | $ 2,580.00 | |
100 mg | 8-10 weeks | $ 3,400.00 |
Description | Emicerfont is an antagonist of the corticotropin-releasing factor type 1 receptor (IC50: 66 nM). |
Targets&IC50 | CRF1 receptor:66 nM |
In vivo | Emicerfont (10 mg/kg) treatment, decreases i.c.v. CRF-induced gerbil forepaw treading and marmoset defensive postures. Emicerfont (30 mg/kg) treatment, also reduces rat pup ultrasonic vocalization. |
Synonyms | GW876008 |
Molecular Weight | 404.46 |
Formula | C22H24N6O2 |
CAS No. | 786701-13-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Emicerfont 786701-13-1 Others GW-876008 GW876008 GW 876008 inhibitor inhibit